Omambac, Guillermo H.
HRN: 07-73-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/26/2022
01/02/2023
IV
600 Mg
Q6H
Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes